Suchergebnisse - "Furusyo, Norihiro"

PubPharm (420)

1

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide : A prospective, multinational study

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Ogawa, E. | Jun, D. | Toyoda, H. | +25

ErratumIn: Aliment Pharmacol Ther. 2024 Jan 19;:. - PMID 38240626

2

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide : A prospective, multinational study

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Ogawa, E. | Jun, D. | Toyoda, H. | +25

3

Relationship between the cholesterol and triglyceride content of lipoprotein subclasses and carotid intima-media thickness : A cross-sectional population-based study

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2023

von Ikezaki, H. | Furusyo, N. | Ai, M. | +5

4

Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication

enthalten in: Journal of medical virology | 2022

von Ohta, A. | Ogawa, E. | Murata, M. | +4

5

Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

enthalten in: The Journal of infectious diseases | 2022

von Ogawa, E. | Nomura, H. | Nakamuta, M. | +19

6

Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B : week 144 results from a real-world, multi-centre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Ogawa, E. | Nakamuta, M. | Koyanagi, T. | +20

CommentIn: Aliment Pharmacol Ther. 2022 Sep;56(6):1090-1091. - PMID 35995741

7

Sequential HBV Treatment With Tenofovir Alafenamide for Patients With Chronic Hepatitis B: Week 96 Results From a Real-world, Multicenter Cohort Study

enthalten in: ResearchSquare.com | 2022

von Ogawa, E. | Nakamuta, M. | Koyanagi, T. | +18

8

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B : week 96 results from a real-world, multicenter cohort study

enthalten in: Hepatology international | 2022

von Ogawa, E. | Nakamuta, M. | Koyanagi, T. | +20

9

Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection

enthalten in: Journal of gastroenterology and hepatology | 2022

von Ogawa, E. | Kawano, A. | Ooho, A. | +20

10

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

enthalten in: Hepatology international | 2022

von Ogawa, E. | Nakamuta, M. | Koyanagi, T. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]